Case Reports archive for October 2025
Aesthetic restoration following GLP-1 agonist–induced facial volume loss
GLP-1 receptor agonists such as semaglutide (Ozempic®, Wegovy®, Rybelsus®) have significantly improved the management of obesity and type 2 diabetes, providing effective weight loss and cardiometabolic benefits. However, as their use becomes more widespread, there has been an increase in...
Ultrasound-guided gluteal augmentation with hyaluronic acid (Variofill®)
Buttock augmentation has gained increasing popularity, driven by the demand for improved body contour and projection. Traditional surgical methods, such as autologous fat grafting or implants, can provide substantial volume but are associated with significant risks, including fat embolism, infection,...
